{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:55:14Z","timestamp":1789977314816,"version":"4.0.1"},"reference-count":10,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T00:00:00Z","timestamp":1438560000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2016,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on the incidence of pneumococcal meningitis (PM) in children is unknown. To determine this impact, a descriptive multicentre retrospective cohort study was conducted from 2008 to 2013 in northern France. All laboratory-confirmed PM in children aged &lt;18 years in all hospitals of the area with paediatric units were included. Two independent databases were used for exhaustive identification of cases: medical plus laboratory records at each hospital and discharge codes. The corrected incidence of PM was determined by a capture\u2013recapture analysis using these two databases. Sixty-two cases were found over the 6-year period. A decrease of the PM corrected incidence was observed in the global population (<jats:italic>P<\/jats:italic> = 0\u00b707), significant only for children aged &lt;2 years, from 11\u00b79\/100 000 in 2008 in 1\u00b79\/100 000 in 2013 [6\u00b74 fold-decrease, 95% confidence interval (CI) 1\u00b74\u201341, <jats:italic>P<\/jats:italic> = 0\u00b701] between years 2008 and 2013. When comparing the pre- and post-PCV13 periods, this decrease was still statistically significant for children aged &lt;2 years [7\u00b732\/100 000 (95% CI 4\u00b739\u201310\u00b725) to 2\u00b778\/100 000 (95% CI 0\u00b796\u20134\u00b760), <jats:italic>P<\/jats:italic> = 0\u00b701]. Only three (5%) cases of PM caused by vaccine serotypes could have been prevented. After the introduction of the PCV13 vaccine, a decrease in the incidence of PM cases in children in northern France was observed.<\/jats:p>","DOI":"10.1017\/s095026881500179x","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T04:01:25Z","timestamp":1438574485000},"page":"607-611","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":13,"title":["Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children"],"prefix":"10.1017","volume":"144","author":[{"given":"A. G.","family":"CHAPOUTOT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"DESSEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"GUILLUY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"LAGR\u00c9E","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"WALLET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"VARON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"MARTINOT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"DUBOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2015,8,3]]},"reference":[{"key":"S095026881500179X_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)00938-7"},{"key":"S095026881500179X_ref5","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.119891"},{"key":"S095026881500179X_ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0051-2"},{"key":"S095026881500179X_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70027-1"},{"key":"S095026881500179X_ref8","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000451"},{"key":"S095026881500179X_ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-013-2260-8"},{"key":"S095026881500179X_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2013.05.016"},{"key":"S095026881500179X_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.032"},{"key":"S095026881500179X_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62225-8"},{"key":"S095026881500179X_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2010.01914.x"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S095026881500179X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T19:00:49Z","timestamp":1555700449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S095026881500179X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S095026881500179X"],"URL":"https:\/\/doi.org\/10.1017\/s095026881500179x","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,3]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2015\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}